[go: up one dir, main page]

US20110313539A1 - Medical supplies and method of producing the same - Google Patents

Medical supplies and method of producing the same Download PDF

Info

Publication number
US20110313539A1
US20110313539A1 US13/000,860 US200913000860A US2011313539A1 US 20110313539 A1 US20110313539 A1 US 20110313539A1 US 200913000860 A US200913000860 A US 200913000860A US 2011313539 A1 US2011313539 A1 US 2011313539A1
Authority
US
United States
Prior art keywords
treatment
iodine
base material
medical supplies
film
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/000,860
Other languages
English (en)
Inventor
Hiroyuki Tsuchiya
Matsufumi Takaya
Masatsugu Maejima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PROSTEC CO Ltd
Original Assignee
PROSTEC CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PROSTEC CO Ltd filed Critical PROSTEC CO Ltd
Assigned to PROSTEC CO., LTD. reassignment PROSTEC CO., LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: TSUCHIYA, HIROYUKI, MAEJIMA, MASATSUGU, TAKAYA, MATSUFUMI
Publication of US20110313539A1 publication Critical patent/US20110313539A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/04—Metals or alloys
    • A61L27/06—Titanium or titanium alloys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/28—Bones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/04—Metals or alloys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104—Silver, e.g. silver sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/106—Halogens or compounds thereof, e.g. iodine, chlorite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/202—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with halogen atoms, e.g. triclosan, povidone-iodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/18—Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment

Definitions

  • This disclosure relates to medical supplies and, particularly, to an improvement in the antimicrobial activity of medical supplies such as artificial bones and osteosynthetic and fixation devices which are implanted in living bodies prior to use.
  • those implants cause the problem that when the implants are grafted in living bodies, infections such as suppuration of diseased parts is caused with high incidence.
  • FIG. 1 is a graph showing the relation between the pore density of a film formed in anodic oxidation treatment and the frequency of pulse current load.
  • FIG. 2 is a graph showing the relation between the thickness of a film formed in anodic oxidation treatment and the frequency of pulse current load.
  • Iodine and iodine compounds have sterilizing activity and antimicrobial activity, and is also used as disinfectants and is said to have little toxicity to living bodies.
  • a Ti alloy (mass % basis, 6% Al-4% V-rest Ti; JIS type-60 alloy) was used as the base material to produce disc-like test piece (plate thickness: 1.5 mm). These test pieces were subjected to degreasing treatment and then to anodic oxidation treatment. In the anodic oxidation treatment, the test piece was electrolyzed at a constant voltage (150 V) for 5 minutes in an acid electrolytic solution (solution temperature: room temperature) of a mixture bath containing sulfuric acid (35 g/l)-phosphoric acid (25 g/l)-aqueous hydrogen peroxide (10 g/l).
  • the current load was made to have an initial current density of 8 A/dm 2
  • the current value was dropped along with passage of time because of the electrolysis at constant voltage. 50 to 10000 Hz pulsed current was used.
  • the test was also made by using direct current (DC) as the current load.
  • the anodically oxidized test piece was cleaned with water and then subjected to iodine-impregnation treatment in which the test piece was dipped in an aqueous iodine compound solution prepared by dissolving 0.5 mass % of a polyvinyl pyrrolidone iodine (PVPI) which was an iodine compound in pure water.
  • PVPI polyvinyl pyrrolidone iodine
  • the test piece was arranged on the anode side and a pure Ti plate was arranged on the cathode side, and the test piece was electrolyzed at a constant voltage of 120 V for 5 minutes to cause electrophoresis, thereby impregnating an oxide film of the surface of the test piece with the iodine compound.
  • the initial current density was set to about 0.2 A/dm 2 . A part of the test pieces were not subjected to the impregnation with iodine compound.
  • the anodically oxidized test pieces were subjected to a scanning electron microscope (magnification: 2500 times) to be used to observe the surface structure of the oxide film formed on the surface of the test piece.
  • Each test piece was observed from five or more visual fields to measure the number of pores formed in the oxide film in each visual field.
  • an arithmetic average of the obtained values was calculated to determine the number of pores of the oxide film formed on the surface of each test piece.
  • the section of each test piece was also observed by a scanning electron microscope (magnification: 2500 times) to measure the thickness of the formed oxide film.
  • an antimicrobial activity test was made by the film covering method according to the provisions of JIS Z 2801. Escherichia coli (JCM 1649 strains) was used as the pathogenic organ and the cells number left after a prescribed time (24 h) passed was measured to evaluate the antimicrobial activity of the test piece. The test was repeated two times each. When the cell numbers left after a prescribed time passed is smaller, the test piece is evaluated to be superior in antimicrobial activity.
  • the antimicrobial activity value is 0 and no improvement in antimicrobial activity is observed.
  • the antimicrobial activity is improved more significantly in the case of performing anodic oxidation treatment by adding pulsed current at a frequency of 50 Hz or more than in the case of performing anodic oxidation treatment by adding direct current. It is clarified that the antimicrobial activity is significantly improved when anodic oxidation treatment is performed by applying pulsed current at a frequency of, particularly, 800 Hz or more and more preferably 1000 to 5000 Hz. This is clarified from the relation between the density of the formed micro pores and the frequency of the pulsed current load in the anodic oxidation treatment as illustrated in FIG. 1 .
  • micro unevennesses means the surface state on which unevennesses having a depth of several micrometers ( ⁇ m) to several hundreds of micrometers (surface roughness Ra: about several micrometers ( ⁇ m) to several hundreds of micrometers ( ⁇ m))exist as these pores are deformed or integrated.
  • Examples of the iodine compound with which the supplies are impregnated may include:
  • hetero-compound polymers such as polyvinyl pyrrolidone iodine, aromatic hydrocarbons and their derivatives such as ⁇ -cyclodextrin iodine or inorganic compounds such as silver iodide are preferable as the iodine compound with which the supplies are impregnated, from the viewpoint of safety to the human body, environmental integrity and biocompatibility.
  • Ti or Co is preferably used if it is a pure metal or a Ti alloy, Co alloy, stainless steel or Co-Cr alloy is preferably used if it is an alloy. It is more preferable to use Ti and Ti alloy, stainless steel or Co-Cr alloy taking it into account to transplant the supplies to living bodies.
  • Ti is preferably pure Ti prescribed as JIS type-1 or JIS type-2 or a Ti alloy prescribed as JIS type-60 (6% Al-4% V-Ti alloy), JIS type-61 (3% Al-2% V-Ti alloy), 15-3-3 alloy, JIS type-11 or JIS type-12 are each applicable.
  • austenite stainless steels such as SUS 302, SUS 304, SUS 316, SUS 316L, SUS 317J4L, SUS 329J1 and SUS 329J3L are preferable from the viewpoint of non-magnetism.
  • Co-Cr alloy a stellite 20 alloy having a composition of 63.0% Cr-6.0% Mo-2.0% Ni-0.25% C-rest Cr is preferable from the viewpoint of strength and corrosion resistance.
  • a base material made of any one of the metallic materials is preferably formed into a predetermined shape and then subjected to degreasing treatment. Then, the base material is subjected to any one of electrochemical treatment, chemical treatment, thermal and/or mechanical treatment or a combination of two or more of these treatments to form a film on the surface of the base material. It is preferable to adopt anodic oxidation treatment as the electrochemical treatment, medicine treatment as the chemical treatment, heating treatment as the thermal treatment, thermal processing treatment as the thermal and mechanical treatment and mechanical processing treatment as the mechanical treatment.
  • the method will be described concerning the case of performing anodic oxidation treatment to form a film on the surface of the base material as an example. It is needless to say that the method is not limited to the anodic oxidation treatment.
  • the acid electrolytic bath may include a sulfuric acid-water mixture bath (for example, content of sulfuric acid: 5 to 30 mass % and preferably 10 to 25 mass %), sulfuric acid-phosphoric acid-water mixture bath (for example, sulfuric acid 35 g/l and phosphoric acid 25 g/l), sulfuric acid-phosphoric acid-aqueous hydrogen peroxide-water mixture bath (for example, sulfuric acid 35 g/l, phosphoric acid 25 g/l, and aqueous hydrogen peroxide 10 g/l), sulfuric acid-phosphoric acid-ascorbic acid-water mixture bath (for example, sulfuric acid 35 g/l, phosphoric acid 25 g/1 and ascorbic acid 10 g/l) and hydrochloric acid-aqueous hydrogen peroxide-formalin-water mixture bath (for example, hydrochloric acid 40 mass %, aqueous hydrogen peroxide 2 mass % and formalin 10 mass %).
  • sulfuric acid-phosphoric acid-water mixture bath for example,
  • the acid electrolytic bath when the base material is Ti or a Ti alloy or stainless steel, and the alkali electrolytic bath when the base material is a Co-Cr alloy.
  • the current applied in the anodic oxidation treatment is preferably 50 to 10000 Hz pulsed current.
  • the frequency is more preferably 1000 to 5000 Hz from the viewpoint of the number of micro-pores to be formed.
  • Medicine treatment as the chemical treatment, heating treatment as the thermal treatment, heating processing treatment as the thermal and mechanical treatment, or mechanical processing treatment as the mechanical treatment or a combination of two or more of these treatments may be adopted in place of the anodic oxidation treatment as the electrochemical treatment.
  • Examples of the medicine treatment may include a method in which a high-temperature alkali-type bath or an acid bath is used and the base material is dipped in this bath to form chemically treated film having micro pores and/or micro unevennesses on the surface of the base material.
  • a method in which as the high-temperature alkali-type bath for example, a 140° C. sodium hydroxide-potassium nitrate-water mixture bath (for example, 60 parts by weight of sodium hydroxide, 40 parts by weight of potassium nitrate and 500 parts by weight of water) is used and the base material is dipped in this bath for 10 minutes and a method in which as the acid bath, for example, a 30° C.
  • oxalic acid-hydrogen peroxide-water mixture bath for example, 25 mass % of oxalic acid (100 g/l) and 3.5 mass % of hydrogen peroxide (30%)
  • This treatment is preferably applied in the case of using stainless steel such as SUS 304 as the base material.
  • examples of the heating treatment may include a method in which the base material is heated (heating temperature: 600 to 800° C. and preferably 700° C. x 1 hr) in the atmosphere to form a film (oxide film) on the surface of the base material.
  • examples of the thermal processing treatment may include methods in which the surface of the base material is irradiated with an electron beam or laser beam.
  • examples of the mechanical processing treatment may include methods using a shot blasting. In these treatments, it is essential to make an examination in advance before determining the treatment conditions so that a film having micro unevennesses or micro pores having a desired surface structure. In this case, these treatments are preferably applied when stainless steel or a Co-Cr alloy is used as the base material.
  • Treatment such as anodic oxidation treatment is performed to form a film having micro pores or micro unevennesses on the surface of the base material and then, iodine-impregnation treatment is carried out to impregnate the film with iodine or iodine compounds.
  • the iodine-impregnation treatment can be carried out as follows: the base material which has been subjected to, for example, anodic oxidation treatment is cleaned with water, then dipped in an aqueous iodine or iodine compound solution and direct current is applied by using the base material as the anode to carry out electrolysis at a constant voltage or constant current density.
  • the aqueous solution used for the electrolysis is preferably an aqueous solution containing 0.1 to 1.0 mass % of iodine or iodine compounds.
  • the amount of iodine or iodine compounds is less than 0.1 mass %, the content of iodine with which the film is impregnated is so small that desired antimicrobial activity cannot be developed. Even if iodine or iodine compound is added in an amount exceeding 1.0 mass % on the other hand, the effect is saturated and this is economically disadvantageous.
  • the amount of iodine or iodine compound is more preferably 0.3 to 0.5 mass %.
  • the iodine compound to be added in the aqueous solution the iodine compounds are all preferable.
  • the iodine compounds are all preferable.
  • these compounds polyvinyl pyrrolidone iodine (PVPI), ⁇ -cyclodextrin iodine (BCDI) and silver iodide are preferable from the viewpoint of biocompatibility.
  • the constant voltage anodizing is preferably carried out at a constant voltage ranging from 100 to 200 V for 1 to 10 minutes.
  • the constant current density anodizing is preferably carried out at a constant current density ranging from 0.05 to 10 A/dm 2 for 1 to 10 minutes.
  • a Ti alloy (mass % basis, 6% Al-4% V-rest Ti; JIS type-60 alloy) and stainless steel (SUS 304) were used as base materials to manufacture discs (plate thickness: 2.0 mm) as test pieces for in vitro test and external fixation pins for a rabbit as test pieces for in vivo test.
  • the Ti alloy test pieces were subjected to degreasing treatment and then to anodic oxidation treatment.
  • the test piece was electrolyzed at a constant voltage (150 V) for 5 minutes in an acid electrolytic solution (solution temperature: ambient temperature) of a mixture bath containing sulfuric acid (35 g/l)-phosphoric acid (25 g/l)-aqueous hydrogen peroxide (10 g/l).
  • solution temperature ambient temperature
  • sulfuric acid 35 g/l
  • phosphoric acid 25 g/l-aqueous hydrogen peroxide
  • the anodically oxidized test pieces (Ti alloy test pieces) were subjected to a scanning electron microscope (magnification: 2500 times) to observe the surface structure of the oxide film formed on one surface of each test piece in five or more visual fields, thereby measuring the number of pores formed in the oxide film in each visual field. Then, an arithmetic average of the values obtained in the visual fields was calculated to determine the number of pores of the oxide film formed on the surface of each test piece. Further, the section of each test piece was observed by a scanning electron microscope (magnification: 2500 times) in five visual fields to measure an average thickness of the oxide film formed on the surface.
  • the anodically oxidized test pieces (Ti alloy test pieces) were cleaned with water for one minute.
  • the test piece was dipped in an aqueous iodine compound solution prepared by dissolving 0.5 mass % of polyvinyl pyrrolidone iodine (PVPI) which was an iodine compound in pure water and the test piece was settled on the anode side and a pure Ti plate was settled on the cathode side to perform electrolysis at a constant voltage of 120 V, thereby carrying out iodine-impregnation treatment.
  • PVPI polyvinyl pyrrolidone iodine
  • the initial current density was set to about 0.2 A/dm 2 to cause electrophoresis to impregnate the oxide film formed on the surface of the test piece with the iodine compound.
  • test pieces which were not anodically oxidized were degreased and cleaned with water for one minute prior to the test.
  • test pieces using a part of these treated obtained test pieces (discs), an antimicrobial activity test was made for in vivo test according to the provisions of JIS Z 2801.
  • As the pathogenic organ Staphylococcus aureus (ATCC 25923) and Escherichia coli (MG 1455) were used. The test was repeated 15 times for each test piece. As the cells number left after a predetermined time passed is smaller, the test piece is evaluated to be superior in antimicrobial activity.
  • test piece semiconductor plate
  • cytotoxicity of the test piece was evaluated for in vitro test by the colony forming method using rat fibroblast cell line V79.
  • the test piece was dipped in a culture fluid contained in a Petri dish and the above V79 was inoculated on the test piece to confirm the formation of colonies for the evaluation.
  • the evaluation items are as follows: inflammation of the pin-pierced part, abscess around the pin, marrow, and inflammation around the tip of the pin.
  • Example (test piece No. A1), the formation of colonies is significantly suppressed, so that the number of Staphylococcus aureus which is about 2000 before the start of the antimicrobial test is reduced to an average of 0.07 after 24 hr and also, the number of Escherichia coli which is about 2000 before the start of the antimicrobial test is reduced to an average of 0 after 24 hr, showing that the Example is superior in antimicrobial activity.
  • the cells number observed after 24 hr is 181 (test piece No. A2) and 347 (test piece No. A3) in the case of Staphylococcus aureus and 1281 (test piece No. A2) and 1600 (test piece No. A3) in the case of Escherichia coli . These differences are statistically significant.
  • the Example reduces inflammation and infection. Further, this difference from the Comparative Examples is also statistically significant and this shows that our Example reduces infection induced by a pin and is superior in antimicrobial activity and biocompatibility. Further, our Example is similar to titanium in good osteoid and bone formation and it may be said that our Example has sufficient osteoconductivity.
  • Stainless steel (SUS 304) was used as a base material to manufacture disc-like test pieces (plate thickness: 2 mm) for an antimicrobial test. These test pieces were each washed with an acid and then subjected to anodic oxidation treatment or to medicine treatment. In the acid washing treatment, the test pieces were dipped in an aqueous mixture solution of nitric acid (5%)-hydrofluoric acid (3%) at a liquid temperature of 40° C. for 3 minutes.
  • test pieces were electrolyzed at a constant voltage (100 V) for 15 minutes by using the test piece as the anode and pure Ti plate as the cathode in an acid electrolytic solution (solution temperature: ambient temperature) of a mixture bath containing hydrochloric acid (47 mass %)-aqueous hydrogen peroxide (2 mass %)-formalin (10 mass %)-water.
  • solution temperature ambient temperature
  • hydrochloric acid 47 mass %)-aqueous hydrogen peroxide (2 mass %)-formalin (10 mass %)-water.
  • pulsed current having a frequency of 3000 Hz was used.
  • the initial current value was 3.5 A/dm 2 .
  • the test pieces were dipped in a 30° C. mixture bath of oxalic acid (25 mass %)-hydrogen peroxide (3.5 mass %)-distilled water which was a high-temperature acid bath for 30 minutes.
  • test pieces which were anodically oxidized or treated using a medicine were subjected to a scanning electron microscope (magnification: 2500 times) to observe the surface structure of the film (oxide film) formed on the surface of each test piece in five or more visual fields, thereby measuring the number of pores formed in the film in each visual field. Then, an arithmetic average of the values obtained in the visual fields was calculated to determine the number of pores of the film formed on the surface of each test piece. Further, the section of each test piece was observed by a scanning electron microscope (magnification: 2500 times) in five visual fields to measure an average thickness of the film formed on the surface.
  • test piece was cleaned with water.
  • test piece was dipped in an aqueous iodine compound solution prepared by dissolving 0.5 mass % of polyvinyl pyrrolidone iodine (PVPI) which was an iodine compound in pure water and the test piece was settled on the anode side and a pure Ti plate was settled on the cathode side to perform electrolysis at a constant voltage of 120 V (direct current (DC)) for 5 minutes to cause electrophoresis, thereby carrying out iodine-impregnation treatment to impregnate the oxide film formed on the surface of the test piece with the iodine compound.
  • DC direct current
  • test pieces which were only anodically oxidized or treated using a medicine and test pieces subjected to iodine-impregnation treatment after anodically oxidized or treated using a medicine
  • an antimicrobial activity test was made by the film covering method according to the provisions of JIS Z 2801.
  • Escherichia coli JCM 1649 strain
  • cell numbers left after a predetermined time (24 h) passed was measured to evaluate the antimicrobial activity. As the cell numbers left after a predetermined time passed decreases, the test piece is evaluated to be superior in antimicrobial activity.
  • a Co-Cr alloy (mass % basis, 63.0% Co-6.0% Mo-2.0% Ni-0.25% C-rest Cr) was used as a base material to manufacture disc-like test pieces (plate thickness: 5.0 mm) for an antimicrobial test. These test pieces were each washed with an acid and then subjected to anodic oxidation treatment.
  • the test piece was electrolyzed at a constant voltage (150 V, direct current (DC)) for 15 minutes by using the test piece as the anode and pure Ti plate as the cathode in an alkali electrolytic solution (solution temperature: room temperature) of a mixture bath containing potassium hydroxide (165 g/l)-potassium fluoride (35 g/l)-sodium phosphate (35 g/l)-aluminum hydroxide (35 g/ 1 )-water.
  • pulsed current having a frequency of 5000 Hz was used.
  • the initial current value was 8 A/dm 2 .
  • test pieces were subjected to a scanning electron microscope (magnification: 2500 times) to observe the surface structure of the film (oxide film) formed on the surface of each test piece, thereby determining the number of pores formed on the surface of each test piece and the average thickness of the film in the same manner as in Example 2.
  • the test piece was dipped in an aqueous iodine compound solution prepared by dissolving 0.5 mass % of polyvinyl pyrrolidone iodine (PVPI) which was an iodine compound in pure water and the test piece was settled on the anode side and a pure Ti plate was settled on the cathode side to perform electrolysis at a constant voltage of 150 V (direct current (DC)) for 5 minutes to cause electrophoresis, thereby carrying out iodine-impregnation treatment to impregnate the oxide film formed on the surface of the test piece with the iodine compound.
  • the initial current density was about 0.2 A/dm 2 .
  • an antimicrobial activity test was made by the film covering method according to the provisions of JIS Z 2801 to evaluate the antimicrobial activity of each test piece in the same manner as in Example 2.
  • the method of evaluation was the same as that of Example 2.
  • Stainless steel (SUS 304) was used as a base material to manufacture disc-test pieces for antimicrobial test (plate thickness: 2 mm) These test pieces were first subjected to shot blasting as mechanical processing treatment of mechanical treatment. The shot blasting was performed using four types of alumina shots one by one. In treatment in a first stage, a #60-mesh alumina shot was used to perform shot blasting under a pressure of 3.5 kg/cm 2 for about 2 minutes carefully from all directions so as not to leave non-blasted part.
  • the surface treated by shot blasting using #60 mesh shot was carefully shot-blasted using a #100-mesh alumina shot in the same pressure and time condition as in the first stage in such a manner as to be equally shot-blasted.
  • the surface treated by shot blasting using #100 mesh shot was carefully shot-blasted using a #150-mesh alumina shot in the same pressure and time condition as in the first and second stage in such a manner as to be equally shot-blasted.
  • the surface treated by shot blasting using #150-mesh shot was shot-blasted using a #200-mesh alumina shot in the same pressure and time condition as above.
  • the surface roughness in the shot-blasted state when measured according to the provisions of JIS B 0601-1994 was as follows: arithmetic average roughness Ra was 2 ⁇ m, maximum height of roughness profile Ry was 55 ⁇ m and ten-point height Rz of roughness profile was 3.5 ⁇ m.
  • the test piece having the surface properties mentioned above was further subjected to medicinal treatment which was chemical treatment.
  • the above test piece was treated by dipping the test piece in a mixture bath containing sulfuric acid (50 g)-oxalic acid (50 g)-water (400 g) at a liquid temperature of 60° C. for one hour.
  • the shot-blasted surface was chemically oxidized into a micronized etching surface having an oxide film on the surface thereof
  • the surface roughness at this time was as follows: arithmetic average roughness Ra was 2.5 ⁇ m, maximum height of roughness profile Ry was 65 ⁇ m and ten-point height Rz of roughness profile was 4.3 ⁇ m.
  • test pieces were subjected to a scanning electron microscope (magnification: 2500 times) to observe the surface structure of the film (oxide film) formed on the surface of each test piece, thereby observing the number of micro unevennesses of the film formed on the surface of each test piece in the same manner as in Example 2.
  • test piece was dipped in an aqueous iodine compound solution (liquid temperature: 25° C.) prepared by dissolving 0.5 mass % of ⁇ -Cyclodextrin iodine (BCDI) which was an iodine compound in pure water and the test piece was settled on the anode side and a pure Ti plate was settled on the cathode side to perform electrolysis at a constant voltage of 150 V (direct current (DC)) for 3 minutes to cause electrophoresis, thereby carrying out iodine-impregnation treatment to electro-deposit the iodine compound on the micro unevennesses of the oxide film formed on the surface of the test piece.
  • the initial current density was about 12 A/dm 2 and the current density was decreased gradually with passage of time.
  • an antimicrobial activity test was made by the film covering method according to the provisions of JIS Z 2801 to evaluate the antimicrobial activity of each test piece in the same manner as in Example 2.
  • the cell numbers at the start of the test were 56000/ml (5.6 ⁇ 10 4 /ml).
  • the method of evaluation was the same as that of Example 2.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
US13/000,860 2009-08-25 2009-08-25 Medical supplies and method of producing the same Abandoned US20110313539A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2009/004096 WO2011024216A1 (ja) 2009-08-25 2009-08-25 医療用部品およびその製造方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2009/004096 A-371-Of-International WO2011024216A1 (ja) 2009-08-25 2009-08-25 医療用部品およびその製造方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/836,425 Division US9889231B2 (en) 2009-08-25 2013-03-15 Medical supplies and method of producing the same

Publications (1)

Publication Number Publication Date
US20110313539A1 true US20110313539A1 (en) 2011-12-22

Family

ID=43627347

Family Applications (3)

Application Number Title Priority Date Filing Date
US13/000,860 Abandoned US20110313539A1 (en) 2009-08-25 2009-08-25 Medical supplies and method of producing the same
US13/836,425 Active US9889231B2 (en) 2009-08-25 2013-03-15 Medical supplies and method of producing the same
US15/895,556 Active US10668187B2 (en) 2009-08-25 2018-02-13 Medical supplies and method of producing the same

Family Applications After (2)

Application Number Title Priority Date Filing Date
US13/836,425 Active US9889231B2 (en) 2009-08-25 2013-03-15 Medical supplies and method of producing the same
US15/895,556 Active US10668187B2 (en) 2009-08-25 2018-02-13 Medical supplies and method of producing the same

Country Status (17)

Country Link
US (3) US20110313539A1 (de)
EP (1) EP2371398B1 (de)
JP (1) JP5044795B2 (de)
KR (1) KR101322942B1 (de)
CN (1) CN102281906B (de)
AU (1) AU2009351845B2 (de)
BR (1) BRPI0919992B8 (de)
CA (1) CA2770362C (de)
ES (1) ES2414635T3 (de)
IL (1) IL217924A (de)
MX (1) MX2011010391A (de)
NZ (1) NZ598179A (de)
PL (1) PL2371398T3 (de)
RU (1) RU2485979C1 (de)
SG (1) SG177768A1 (de)
WO (1) WO2011024216A1 (de)
ZA (1) ZA201200882B (de)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013130431A1 (en) * 2012-03-02 2013-09-06 DePuy Synthes Products, LLC Anodized titanium devices and related methods
EP3391915A2 (de) 2017-03-30 2018-10-24 Biomet Manufacturing, LLC Verfahren zur modifizierung der porösen oberfläche von implantaten
US10940234B2 (en) * 2017-03-31 2021-03-09 Prostec Co., Ltd. Method for producing antibacterial biological implant
US10980914B2 (en) 2017-03-31 2021-04-20 Prostec Co., Ltd. Antibacterial biological implant
US10980921B2 (en) 2010-02-05 2021-04-20 Orthomedex Llc Methods of using water-soluble inorganic compounds for implants
CN114129768A (zh) * 2021-11-08 2022-03-04 浙江大学 一种抗感染的改良型载碘钛合金抗菌植入物及制备方法

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102417741A (zh) * 2011-05-24 2012-04-18 周君琳 碘抗菌羟基磷灰石涂层钛和钛合金内植物的设计和制备
CN102416202A (zh) * 2011-05-24 2012-04-18 周君琳 碘抗菌钛合金骨科内固定钉板的设计和制作方法
JP2013172926A (ja) * 2012-02-27 2013-09-05 Japan Lifeline Co Ltd 医療用ガイドワイヤ
WO2014203566A1 (ja) * 2013-06-18 2014-12-24 オリンパス株式会社 生体用インプラント
CN111660629A (zh) * 2014-04-09 2020-09-15 积水化学工业株式会社 汽车用挡风玻璃用中间膜、辊状体及汽车用挡风玻璃
US11565507B2 (en) 2014-04-09 2023-01-31 Sekisui Chemical Co., Ltd. Laminated-glass intermediate film, rolled body, laminated glass, and method for producing laminated glass
GB201508385D0 (en) * 2015-05-15 2015-07-01 Accentus Medical Ltd Metal treatment
CN105396173B (zh) * 2015-11-20 2018-06-29 广西中医药大学 利用铑配合物制备具有抗菌抗癌性能的不锈钢的方法
UA113360C2 (xx) * 2015-12-07 2017-01-10 Імплантат
RU2616670C1 (ru) * 2015-12-18 2017-04-18 Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский Томский политехнический университет" Способ нанесения иода и его соединений на поверхность изделий из полимолочной кислоты
CN105821324A (zh) * 2016-05-05 2016-08-03 苏州蔻美新材料有限公司 一种骨科合金材料及其制备方法
RU2647968C1 (ru) * 2017-02-27 2018-03-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский государственный технический университет имени Гагарина Ю.А." (СГТУ имени Гагарина Ю.А.) Способ формирования титановых пористых покрытий на титановых имплантатах
CN107829123B (zh) * 2017-10-09 2020-05-12 深圳市中科摩方科技有限公司 一种表面双层涂层的铝合金及其制备方法和应用
CN108315795B (zh) * 2018-03-06 2019-08-23 福建省南平铝业股份有限公司 一种抗菌铝材的制作方法
JP7204153B2 (ja) * 2018-09-28 2023-01-16 三菱ケミカル株式会社 抗菌性積層体、及び抗菌性積層体の製造方法
CN111733436A (zh) * 2020-06-19 2020-10-02 浙江大学 一种银碘表面修饰的钛合金植入物及其制备方法
CN111588904B (zh) * 2020-06-19 2021-06-04 浙江大学 含聚己内酯/聚维酮碘表层的载碘钛合金医用部件及其制作方法
CN111763978B (zh) * 2020-06-30 2021-10-15 南京同曦同康抗菌材料科技有限公司 一种抗菌抗病毒铝合金及其制备方法
CN111763980B (zh) * 2020-06-30 2021-10-29 南京同曦同康抗菌材料科技有限公司 一种抗菌抗病毒不锈钢及其制备方法
US20240207482A1 (en) * 2022-12-16 2024-06-27 Rohit Khanna Surface treatment methods for cementless implantable medical devices

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06248494A (ja) * 1993-02-23 1994-09-06 Nippon Alum Co Ltd Ｔｉ合金の陽極酸化皮膜形成方法
US5478237A (en) * 1992-02-14 1995-12-26 Nikon Corporation Implant and method of making the same
JP2003073207A (ja) * 2001-08-29 2003-03-12 Fujikura Ltd 抗菌材
US20060016690A1 (en) * 2004-07-23 2006-01-26 Ilya Ostrovsky Method for producing a hard coating with high corrosion resistance on articles made anodizable metals or alloys
US20070016163A1 (en) * 2005-06-28 2007-01-18 Microchips, Inc. Medical and dental implant devices for controlled drug delivery
WO2007074968A1 (en) * 2005-12-26 2007-07-05 Cowellmedi Co., Ltd. Dental implant coated with recombinant bone morphogenic protein and coating method thereof
WO2008056323A1 (en) * 2006-11-10 2008-05-15 Sandvik Intellectual Property Ab Surgical implant composite materials and kits and methods of manufacture
WO2009044203A1 (en) * 2007-10-03 2009-04-09 Accentus Plc Method of manufacturing metal with biocidal properties

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS547267B2 (de) * 1973-09-21 1979-04-05
US4323055A (en) * 1980-04-08 1982-04-06 Minnesota Mining And Manufacturing Company Radioactive iodine seed
GB9808052D0 (en) * 1998-04-17 1998-06-17 Secr Defence Implants for administering substances and methods of producing implants
DE19948783C2 (de) * 1999-02-18 2001-06-13 Alcove Surfaces Gmbh Implantat
US7192445B2 (en) 2000-12-06 2007-03-20 Astra Tech Ab Medical prosthetic devices and implants having improved biocompatibility
JP5068918B2 (ja) * 2000-12-06 2012-11-07 ストラウマン ホールディング アーゲー 生体適合性が向上した医療用プロテーゼ装置およびインプラント
AU2003257604A1 (en) 2002-08-23 2004-03-29 Bridgestone Corporation Stent and process for producing the same
BRPI0414843A (pt) * 2003-09-30 2006-11-21 John Arthur Disegi revestimentos de ácido hialurÈnico antimicrobiais para implantes ortopédicos
CN100368600C (zh) * 2003-12-09 2008-02-13 中南大学 生物陶瓷膜的制备方法
TWI261629B (en) * 2003-12-11 2006-09-11 Ind Tech Res Inst Surface treatment process for enhancing the release of metal ions from sacrificial electrode and sacrificial electrode prepared by said process
CN100427379C (zh) * 2004-03-19 2008-10-22 中国科学院固体物理研究所 纳米单晶锑丝/三氧化二铝有序介孔复合体及制备方法
JP2008006164A (ja) 2006-06-30 2008-01-17 Yoshioka:Kk 酸化膜の形成方法
RU2325133C1 (ru) * 2006-08-30 2008-05-27 Алексей Вячеславович Архипов Внутрикостный дентальный имплантат
US20080147186A1 (en) * 2006-12-14 2008-06-19 Joshi Ashok V Electrochemical Implant For Delivering Beneficial Agents
DE102009032228A1 (de) 2009-07-08 2011-01-13 Giesecke & Devrient Gmbh Vorrichtung und Verfahren für die Annahme oder Ausgabe von Banknoten

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478237A (en) * 1992-02-14 1995-12-26 Nikon Corporation Implant and method of making the same
JPH06248494A (ja) * 1993-02-23 1994-09-06 Nippon Alum Co Ltd Ｔｉ合金の陽極酸化皮膜形成方法
JP2003073207A (ja) * 2001-08-29 2003-03-12 Fujikura Ltd 抗菌材
US20060016690A1 (en) * 2004-07-23 2006-01-26 Ilya Ostrovsky Method for producing a hard coating with high corrosion resistance on articles made anodizable metals or alloys
US20070016163A1 (en) * 2005-06-28 2007-01-18 Microchips, Inc. Medical and dental implant devices for controlled drug delivery
WO2007074968A1 (en) * 2005-12-26 2007-07-05 Cowellmedi Co., Ltd. Dental implant coated with recombinant bone morphogenic protein and coating method thereof
WO2008056323A1 (en) * 2006-11-10 2008-05-15 Sandvik Intellectual Property Ab Surgical implant composite materials and kits and methods of manufacture
WO2009044203A1 (en) * 2007-10-03 2009-04-09 Accentus Plc Method of manufacturing metal with biocidal properties

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Hiratsuka, K; et. al. "Effect of impregnation of iodine complex on friction of anodic oxide of aluminum" Tribology Letters, Vol. 13, No. 2, 2002, 77-80. *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10980921B2 (en) 2010-02-05 2021-04-20 Orthomedex Llc Methods of using water-soluble inorganic compounds for implants
WO2013130431A1 (en) * 2012-03-02 2013-09-06 DePuy Synthes Products, LLC Anodized titanium devices and related methods
KR20140132387A (ko) * 2012-03-02 2014-11-17 신세스 게엠바하 양극산화처리된 티타늄 장치 및 관련 방법
CN104870027A (zh) * 2012-03-02 2015-08-26 新特斯有限责任公司 阳极化的钛装置以及相关方法
EP3391915A2 (de) 2017-03-30 2018-10-24 Biomet Manufacturing, LLC Verfahren zur modifizierung der porösen oberfläche von implantaten
US10893944B2 (en) 2017-03-30 2021-01-19 Biomet Manufacturing, Llc Methods of modifying the porous surface of implants
EP3981444A1 (de) 2017-03-30 2022-04-13 Biomet Manufacturing, LLC Procédés de modification de la surface poreuse d'implants
US11395740B2 (en) 2017-03-30 2022-07-26 Biomet Manufacturing, Llc Methods of modifying the porous surface of implants
US10940234B2 (en) * 2017-03-31 2021-03-09 Prostec Co., Ltd. Method for producing antibacterial biological implant
US10980914B2 (en) 2017-03-31 2021-04-20 Prostec Co., Ltd. Antibacterial biological implant
CN114129768A (zh) * 2021-11-08 2022-03-04 浙江大学 一种抗感染的改良型载碘钛合金抗菌植入物及制备方法

Also Published As

Publication number Publication date
BRPI0919992B8 (pt) 2021-06-22
JPWO2011024216A1 (ja) 2013-01-24
US20130240365A1 (en) 2013-09-19
RU2485979C1 (ru) 2013-06-27
KR20120062830A (ko) 2012-06-14
JP5044795B2 (ja) 2012-10-10
CA2770362C (en) 2013-12-03
US20180243483A1 (en) 2018-08-30
EP2371398A4 (de) 2011-11-02
AU2009351845A1 (en) 2012-03-08
PL2371398T3 (pl) 2013-08-30
US10668187B2 (en) 2020-06-02
EP2371398A1 (de) 2011-10-05
EP2371398B1 (de) 2013-05-15
IL217924A0 (en) 2012-03-29
ZA201200882B (en) 2013-05-29
MX2011010391A (es) 2012-01-20
NZ598179A (en) 2013-06-28
IL217924A (en) 2014-11-30
CA2770362A1 (en) 2011-03-03
HK1161845A1 (en) 2012-08-10
ES2414635T3 (es) 2013-07-22
CN102281906A (zh) 2011-12-14
SG177768A1 (en) 2012-03-29
BRPI0919992B1 (pt) 2020-12-29
US9889231B2 (en) 2018-02-13
WO2011024216A1 (ja) 2011-03-03
BRPI0919992A2 (pt) 2020-08-11
CN102281906B (zh) 2014-08-27
KR101322942B1 (ko) 2013-10-29
AU2009351845B2 (en) 2012-12-20

Similar Documents

Publication Publication Date Title
US10668187B2 (en) Medical supplies and method of producing the same
Tong et al. Degradation behavior, cytotoxicity, hemolysis, and antibacterial properties of electro-deposited Zn–Cu metal foams as potential biodegradable bone implants
CN107460371B (zh) 一种Zn-Li系锌合金及其制备方法与应用
Wu et al. Research progress on surface treatments of biodegradable Mg alloys: a review
Xiang et al. Surface modification of pure zinc by acid etching: accelerating the corrosion rate and enhancing biocompatibility and antibacterial characteristics
CN101461964A (zh) 一种生物医用可降解镁合金的生物活性表面改性方法
Weng et al. Osteogenic activity, antibacterial ability, and Ni release of Mg-incorporated Ni-Ti-O nanopore coatings on NiTi alloy
Xu et al. Degradability and biocompatibility of magnesium-MAO: the consistency and contradiction between in-vitro and in-vivo outcomes
Zhai et al. Fluoride coatings on magnesium alloy implants
Rabeeh et al. Iron–gold composites for biodegradable implants: in vitro investigation on biodegradation and biomineralization
Billah et al. A review on surface modification of NiTinol for biomedical applications
Tsou et al. Anticorrosive, Antimicrobial, and Bioactive Titanium Dioxide Coating for Surface‐modified Purpose on Biomedical Material
JP2010515513A (ja) 金属インプラント
HK1161845B (en) Medical supplies and method of producing the same
Pesode et al. Biocompatibility of Plasma Electrolytic Oxidation Coated Titanium Alloy for Biomedical Applications
Kobayashi et al. Micro-arc oxidation for balancing antibacterial activity and bone formation on titanium surface
Xu et al. Effect of Anodic Oxidation on Antibacterial Properties and Biocompatibility of Ti‐13Nb‐13Zr‐3Cu for Biomedical Application
Simi et al. Development and characterization of zinc incorporated titania nanotube arrays for biomedical applications
Zhong et al. Study on the Enhanced Degradable Rate of the Zn-0.4 Li Alloys as Biodegradable Implants by Anodization
EP4467167A1 (de) Verfahren zur beschichtung eines medizinischen geräts, insbesondere zur herstellung von antithrombogenen und antibakteriellen titanwerkstoffen und deren legierungen
Husak et al. Corrosion and biocompatibility improvement of HA-coated magnesium-based alloys as bone implant materials
Shi et al. CuO/Cu2O Coatings via Plasma Electrolytic Oxidation on Ti–4.5 Cu Alloy: A Synergistic Approach to Antibacterial Properties and Cytocompatibility
Malik et al. Antibacterial coatings for improving the performance of biomaterials
Wang et al. Development of Magnesium Alloy as Biodegradable Material
Raghu et al. Fluoride Surface Coating On Magnesium Alloy And Analysis Of Various Test To Improve Corrosion Resistance For Orthopaedical Application

Legal Events

Date Code Title Description
AS Assignment

Owner name: PROSTEC CO., LTD., JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:TSUCHIYA, HIROYUKI;TAKAYA, MATSUFUMI;MAEJIMA, MASATSUGU;SIGNING DATES FROM 20101206 TO 20101210;REEL/FRAME:025764/0593

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: ADVISORY ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: ADVISORY ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STCV Information on status: appeal procedure

Free format text: NOTICE OF APPEAL FILED

STCV Information on status: appeal procedure

Free format text: APPEAL BRIEF (OR SUPPLEMENTAL BRIEF) ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: TC RETURN OF APPEAL

STCV Information on status: appeal procedure

Free format text: ON APPEAL -- AWAITING DECISION BY THE BOARD OF APPEALS

STCV Information on status: appeal procedure

Free format text: BOARD OF APPEALS DECISION RENDERED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION